As partnering transactions continue at record-breaking rates and deals continue as the defining industry trend, the critical question confronting big pharma is not if they should embrace earlier stage deals, but how to best take advantage of them. As the top 20 big pharma companies attend
Lees meer..

Birds have evolved an unusual breathing system, and clues to its development lie in the remains of a recently-discovered 10-meter-long predatory dinosaur from the banks of Argentina’s Rio Colorado. The findings of paleontologist Paul Sereno (National Geographic Explorer-in-Residence at University of Chicago) and colleagues are published on September 30 in the open-access journal PLoS ONE. “Among land animals, birds have a unique way of breathing.
Lees meer..

An article published in the open-access journal PLoS Biology reports on DNA loop formation - one very important process in the regulation of gene expression. Researchers from Brandeis University used state-of-the-art tools to observe a protein involved in regulating DNA transcription. Lac repressor is a protein from the bacterium E.
Lees meer..

From pharmaceutical company funding to the mentioning of brand name medications, there are several potential sources of bias in medical news media coverage. According to a report published in the October 1 issue of JAMA, news articles frequently fail to report these sources of bias and other conflicts of interest. Both physicians and laymen consider news articles an important source of medical information. Michael Hochman, M.D.
Lees meer..

PTC Therapeutics, Inc. (PTC) announced promising findings in patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) at the 13th International World Muscle Society (WMS) Congress. Results from an observational study assessing the utility of the 6-minute walk test (6MWT) as a primary outcome measure in trials of treatment for DMD/BMD showed that the 6MWT clearly differentiates boys with DMD from healthy boys, especially when adjusted for age.
Lees meer..

Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced the initiation of a Phase III clinical trial of the Company’s novel octreotide implant for acromegaly. This trial is designed to test the efficacy, safety and tolerability of the octreotide implant in patients with acromegaly. The implant utilizes the Company’s patented HYDRON(R) Polymer Technology to deliver effective levels of octreotide for six months.
Lees meer..

Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc announced preliminary top-line results from a phase II clinical trial of cariprazine (RGH-188), an investigational antipsychotic, in patients with acute mania associated with bipolar I disorder.
Lees meer..

Oudere borstkankerpatiënt slechter af
Lees meer..

Langdurige borstvoeding geeft minder kans op kanker
Lees meer..

Erfelijkheidstesten voor de zwangerschap op basis van etniciteit
Lees meer..